Wai‐Kay Seto
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 197
- Hepatitis C virus research 166
- Hepatitis Viruses Studies and Epidemiology 23
- Liver Disease and Transplantation 19
- Liver Diseases and Immunity 8
- Epidemiology 222
- Hepatitis B Virus Studies 182
- Liver Disease Diagnosis and Treatment 156
- Co-authors
- Man‐Fung YuenChing‐Lung LaiJames FungDanny Ka‐Ho WongLung‐Yi MakKa Shing CheungFung‐Yu HuangDanny Wong
- Journals
- Journal of Hepatology (24 papers)Hepatology International (12 papers)Journal of Viral Hepatitis (12 papers)PLoS ONE (12 papers)Gut (11 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Wai‐Kay Seto
253 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 5.8k
- Epidemiology 6.5k
- Infectious Diseases 514
- Cancer Research 292
- Oncology 455
Countries citing papers authored by Wai‐Kay Seto
This map shows the geographic impact of Wai‐Kay Seto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai‐Kay Seto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai‐Kay Seto more than expected).
Fields of papers citing papers by Wai‐Kay Seto
This network shows the impact of papers produced by Wai‐Kay Seto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai‐Kay Seto. The network helps show where Wai‐Kay Seto may publish in the future.
Co-authors
The 25 scholars most cited alongside Wai‐Kay Seto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 35 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 56 | |
| 16 | 2020 | 8 | |
| 17 | 2019 | 5 | |
| 18 | 2019 | 8 | |
| 19 | 2018 | 54 | |
| 20 | 2017 | 155 |
About Wai‐Kay Seto
Wai‐Kay Seto is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Endocrinology, Diabetes and Metabolism and Gastroenterology, having authored 264 papers that have together received 7.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (182 papers), Hepatitis C virus research (166 papers), Liver Disease Diagnosis and Treatment (156 papers), Hepatitis Viruses Studies and Epidemiology (23 papers), Liver Disease and Transplantation (19 papers), Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (8 papers) and Liver Diseases and Immunity (8 papers). The work is most often cited by research in Hepatology (5.8k citations), Epidemiology (6.5k citations), Infectious Diseases (514 citations), Cancer Research (292 citations) and Oncology (455 citations). Wai‐Kay Seto has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Man‐Fung Yuen, Ching‐Lung Lai, James Fung, Danny Ka‐Ho Wong, Lung‐Yi Mak, Ka Shing Cheung, Fung‐Yu Huang, Danny Wong, Ran Zhu and Rex Wan‐Hin Hui. Their work appears in journals such as Journal of Hepatology, Hepatology International, Journal of Viral Hepatitis, PLoS ONE and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.